查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1662638

生物材料傷口敷料市場預測至 2030 年：按產品類型、材料類型、分銷管道、應用、最終用戶和地區進行的全球分析

Biomaterial Wound Dressing Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球生物材料傷口敷料市場預計在 2024 年達到 62.8 億美元，預計到 2030 年將達到 102 億美元，預測期內的複合年成長率為 8.4%。

生物材料傷口敷料是用於創傷治療和預防感染的先進材料。這些敷料由天然或合成的生物材料組成，例如矽膠、膠原蛋白、幾丁聚醣和藻酸鹽，可促進身體的癒合過程。它們可以形成一道抵禦細菌的屏障，吸收滲出液，並創造一個潮濕的環境。生物材料傷口敷料常用於燒燙傷、慢性傷口、手術傷口和其他創傷性損傷，因為它們比傳統傷口護理癒合更快、留下的疤痕更少。

根據2022年1月更新的國家糖尿病統計報告，美國約有3,730萬人患有糖尿病，約佔總人口的11.3%。

慢性傷口增多

隨著人口老化以及糖尿病和肥胖症發病率的增加，糖尿病足潰瘍、壓瘡和靜脈性腿部潰瘍等慢性傷口變得越來越普遍。這些傷口通常需要特殊護理並且難以癒合。生物材料傷口敷料由膠原蛋白、水凝膠和藻酸鹽等尖端材料製成，可透過維持濕潤環境、預防感染和減少疤痕的出現來提高癒合品質。隨著患有慢性疾病的人數不斷增加，對高效、先進的創傷護理產品（尤其是生物材料和敷料）的需求預計將呈指數級成長。

缺乏報銷政策

與傳統的傷口護理解決方案相比，許多新型生物材料敷料儘管具有卓越的創傷治療，但價格昂貴。病患和醫療專業人員可能會因為財務問題而猶豫是否使用這些尖端治療方法，尤其是在保險報銷系統有限或不完美的地區。沒有保險的患者和新興市場探險者可能會受到最大影響。生物材料敷料的廣泛使用往往因缺乏報銷而受到限制，從而減緩了市場成長，並使公司更難成功進入價格敏感的市場。

對更快、更有效的創傷治療的需求日益增加

膠原蛋白蛋白、親水膠體和水凝膠敷料是一些先進生物材料敷料的例子，它們可以減少疤痕、降低感染風險並促進快速組織再生。透過創造濕潤的傷口環境，這些敷料可以幫助患者更快癒合並減少不適。醫療保健專業人員對生物材料傷口敷料的使用推動了對此類尖端解決方案的需求。生物材料傷口敷料不僅可以加快癒合過程，而且由於更加重視改善患者治療效果和降低醫療成本，還可以提供更高的舒適度和保護。

醫療專業人員的產品知識有限

儘管現代創傷護理產品（如生物材料敷料）具有顯著的益處，包括加快癒合速度、預防感染疾病和減少疤痕，但許多醫療保健專業人員可能並未完全了解其好處或正確使用方法。這種無知可能會導致這種最尖端科技的利用不足，特別是在傳統傷口護理仍然普遍的地區。為了增加生物材料敷料的使用量並改善患者的治療效果，需要對醫療保健專業人員進行有關其功效和正確使用的教育，這將有助於擴大整個市場。

COVID-19 的影響

COVID-19 疫情以多種方式影響了生物材料傷口敷料市場。雖然停業和經濟放緩最初擾亂了供應鏈並減少了某些領域的需求，但這場大流行凸顯了創傷護理在醫療保健環境中的重要性。由於對感染預防和控制的重視程度不斷提高，加上需要就醫的新冠肺炎患者數量突然增加，導致某些類型的傷口敷料的需求暫時增加。然而，整體影響將根據具體調味料類型和當地市場情況而有所不同。

泡棉敷料市場預計將成為預測期內最大的市場

預測期內，泡棉敷料將佔據最大的市場佔有率。泡棉敷料非常適合處理中度至重度滲出傷口，可有效吸收液體，同時保持傷口濕潤環境以促進癒合。它的緩衝作用可以減輕疼痛並提供額外的保護，使其成為慢性傷口、手術部位和壓瘡的理想選擇。此外，由於其易於應用和移除，在傷口護理中越來越受歡迎。

預計預測期內醫院和診所部門將以最高的複合年成長率成長。

由於對先進創傷護理解決方案的需求很高，預計醫院和診所部門將在預測期內見證最高成長率。在這些醫療環境中，患有慢性傷口、手術傷口和燒傷的患者需要有效、快速癒合的產品。事實證明，生物材料和敷料具有顯著的益處，包括改善感染控制、加速癒合時間和減少併發症。隨著醫院和診所尋求改善患者的治療效果並降低醫療成本，採用可提供最佳癒合環境的生物材料傷口敷料越來越成為這些機構的優先事項。

比最大的地區

由於慢性傷口、燒傷和糖尿病相關疾病的發生率不斷上升，預計亞太地區將在預測期內佔據最大的市場佔有率。印度和中國等國家快速的都市化、不斷增強的醫療意識和不斷擴大的醫療保健基礎設施正在推動對先進創傷護理解決方案的需求。此外，該地區人口老化，老年人更容易受到傷口的影響，需要使用生物材料敷料進行有效治療，以加速癒合並預防感染。

複合年成長率最高的地區

預計北美地區在預測期內將呈現最高的複合年成長率。這是由於醫療費用高昂、醫療基礎設施先進以及人口老化所造成的。慢性傷口、糖尿病和外科手術的增加推動了對先進創傷護理產品的需求。醫院、診所和家庭護理機構擴大採用生物材料敷料，因為它們可以加快癒合速度、預防感染並提高患者舒適度，這對北美市場產生了積極影響。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球生物材料傷口敷料市場依產品類型分類

  • 介紹
  • 泡棉敷料
  • 親水膠體敷料
  • 水凝膠
  • 膜敷料
  • 複合敷料
  • 其他

6. 全球生物材料傷口敷料市場（依材料類型）

  • 介紹
  • 膠原蛋白
  • 幾丁聚醣
  • 矽膠
  • 親水膠體
  • 表格
  • 海藻酸鹽
  • 其他

7. 全球生物材料傷口敷料市場依通路分類

  • 介紹
  • 直接銷售
  • 零售藥局
  • 網上銷售
  • 醫院和醫療保健提供者

8. 全球生物材料傷口敷料市場（依應用）

  • 介紹
  • 急性傷口
    • 手術傷口
    • 燒傷
  • 慢性傷口
    • 糖尿病足潰瘍
    • 靜脈性腿部潰瘍
    • 壓瘡
  • 創傷
  • 其他

9. 全球生物材料傷口敷料市場（依最終使用者）

  • 介紹
  • 醫院和診所
  • 居家醫療
  • 門診手術中心
  • 長期照護機構
  • 其他

第 10 章全球生物材料傷口敷料市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • 3M Health Care
  • Johnson & Johnson
  • Smith & Nephew
  • Medtronic
  • Molnlycke Health Care
  • ConvaTec Group
  • Coloplast
  • BSN Medical
  • Hollister Incorporated
  • Systagenix Wound Management
  • Derma Sciences
  • KCI
  • B. Braun Melsungen AG
  • 美美國
  • Integra LifeSciences Corporation
Product Code: SMRC28499

According to Stratistics MRC, the Global Biomaterial Wound Dressing Market is accounted for $6.28 billion in 2024 and is expected to reach $10.20 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Biomaterial Wound Dressing are advanced materials which are intended for wound healing and prevent infection. These dressings, which promote the body's healing processes, are composed of natural or synthetic biomaterials such silicone, collagen, chitosan, and alginates. They offer a barrier against germs, absorb exudate, and produce a moist environment. Biomaterial wound dressings, which offer faster healing times and less scarring than conventional wound care treatments, are frequently used for burns, chronic wounds, surgical wounds, and other traumas.

According to the National Diabetes Statistics Report updated in January 2022, around 37.3 million people in the United States have diabetes, which equates to around 11.3% of the total population.

Market Dynamics:

Driver:

Rising incidence of chronic wounds

As the population ages and diabetes and obesity rates rise, chronic wounds including diabetic foot ulcers, pressure ulcers, and venous leg ulcers are becoming more prevalent. These wounds frequently need specialized care and are challenging to cure. By preserving a moist environment, avoiding infection, and lessening scarring, biomaterial wound dressings-which comprise cutting-edge materials like collagen, hydrogels, and alginates-offer improved healing qualities. The need for efficient, cutting-edge wound care products, especially biomaterial dressings, is anticipated to expand sharply as the number of people with chronic illnesses keeps growing.

Restraint:

Lack of reimbursement policies

Compared to conventional wound care solutions, many new biomaterial dressings are more expensive despite providing better wound healing advantages. Patients and healthcare professionals may be hesitant to use these cutting-edge treatments in areas with limited or incomplete reimbursement schemes because of financial concerns. Individuals without full health coverage or those in developing markets may be most affected by this. The widespread use of biomaterial dressings is frequently restricted by the lack of reimbursement, which slows market growth and makes it more challenging for businesses to successfully enter price-sensitive markets.

Opportunity:

Growing demand for faster and efficient wound healing

Collagen-based, hydrocolloid, and hydrogel dressings are examples of advanced biomaterial dressings that decrease scarring, lower the risk of infection, and encourage quick tissue regeneration. By creating a moist wound environment, these dressings help patients heal more quickly and experience less discomfort. The demand for these cutting-edge solutions is being driven by healthcare professionals' use of biomaterial wound dressings, which not only speed up the healing process but also offer improved comfort and protection, as a result of the growing emphasis on improving patient outcomes and lowering healthcare costs.

Threat:

Limited product knowledge among healthcare providers

Many healthcare practitioners might not be completely aware of the benefits of modern wound care products, such as biomaterial dressings, or the correct administration procedures, despite the fact that these products offer substantial advantages like faster healing, infection control, and less scarring. This ignorance may lead to the underuse of these cutting-edge technologies, especially in areas where conventional wound care practices are still widely used. Increasing the use of biomaterial dressings and improving patient outcomes need educating healthcare professionals on their efficacy and appropriate usage, which will assist the market's overall expansion.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the biomaterial wound dressing market. While lockdowns and economic slowdowns initially disrupted supply chains and reduced demand in some sectors, the pandemic also highlighted the importance of wound care in healthcare settings. Increased focus on infection prevention and control measures, along with the surge in COVID-19 patients requiring medical attention, led to a temporary increase in demand for certain types of wound dressings. However, the overall impact varied depending on the specific type of dressing and regional market conditions.

The foam dressings segment is expected to be the largest during the forecast period

The foam dressings segment is expected to account for the largest market share during the forecast period. Foam dressings are ideal for managing moderate to heavy exudating wounds, as they efficiently absorb fluids while maintaining a moist wound environment, which accelerates healing. Their cushioning effect reduces pain and provides additional protection, making them a preferred choice for chronic wounds, surgical sites, and pressure ulcers. Additionally, their ease of application and removal contributes to their rising popularity in wound care.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals and clinics segment is predicted to witness the highest growth rate, due to their high demand for advanced wound care solutions. These healthcare settings require effective, fast-healing products for patients with chronic wounds, surgical wounds, and burns. Biomaterial dressings offer superior benefits like infection control, faster healing times, and reduced complications. As hospitals and clinics aim to improve patient outcomes and reduce healthcare costs, the adoption of biomaterial wound dressings, which provide optimal healing environments, is increasingly prioritized in these facilities.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to the rising prevalence of chronic wounds, burns, and diabetic-related conditions. Rapid urbanization, rising healthcare awareness and the expansion of healthcare infrastructure in countries like India and China are driving the demand for advanced wound care solutions. Additionally, the aging population in the region further contributes to the market growth, as elderly individuals are more prone to wounds that require effective treatment with biomaterial dressings for faster healing and infection control.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by high healthcare spending, advanced medical infrastructure, and a growing aging population. With an increasing prevalence of chronic wounds, diabetes, and surgical procedures, the demand for advanced wound care products is on the rise. The adoption of biomaterial dressings, which offer faster healing, infection prevention, and improved patient comfort, is growing across hospitals, clinics, and home care settings, positively influencing the market in North America.

Key players in the market

Some of the key players profiled in the Biomaterial Wound Dressing Market include 3M Health Care, Johnson & Johnson, Smith & Nephew, Medtronic, Molnlycke Health Care, ConvaTec Group, Coloplast, BSN Medical, Hollister Incorporated, Systagenix Wound Management, Derma Sciences, KCI, B. Braun Melsungen AG, Medi-USA, and Integra LifeSciences Corporation.

Key Developments:

In January 2025, Molnlycke Health Care, a world-leading MedTech company specialising in wound care solutions, announced an investment of USD 8 million in Siren. The healthcare tech company Siren is on a mission to help reduce the risk of diabetic foot ulcers by early detection of potential injuries through temperature-sensing textile technology.

In January 2025, Johnson & Johnson strengthens neuroscience leadership with acquisition of intra-cellular therapies, Inc. Acquisition includes CAPLYTA(R) (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults.

In December 2024, Smith+Nephew expands AETOS shoulder system with new stemless option for anatomic shoulder arthroplasty. Smith+Nephew announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total shoulder for the AETOS Shoulder System (AETOS Stemless).

Product Types Covered:

  • Foam Dressings
  • Hydrocolloid Dressings
  • Hydrogels
  • Film Dressings
  • Composite Dressings
  • Other Product Types

Material Types Covered:

  • Collagen
  • Chitosan
  • Silicone
  • Hydrocolloid
  • Foam
  • Alginate
  • Other Material Types

Distribution Channels Covered:

  • Direct Sales
  • Retail Pharmacies
  • Online Sales
  • Hospitals and Healthcare Providers

Applications Covered:

  • Acute Wounds
  • Chronic Wounds
  • Traumatic Wounds
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Long-Term Care Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biomaterial Wound Dressing Market, By Product Type

  • 5.1 Introduction
  • 5.2 Foam Dressings
  • 5.3 Hydrocolloid Dressings
  • 5.4 Hydrogels
  • 5.5 Film Dressings
  • 5.6 Composite Dressings
  • 5.7 Other Product Types

6 Global Biomaterial Wound Dressing Market, By Material Type

  • 6.1 Introduction
  • 6.2 Collagen
  • 6.3 Chitosan
  • 6.4 Silicone
  • 6.5 Hydrocolloid
  • 6.6 Foam
  • 6.7 Alginate
  • 6.8 Other Material Types

7 Global Biomaterial Wound Dressing Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Retail Pharmacies
  • 7.4 Online Sales
  • 7.5 Hospitals and Healthcare Providers

8 Global Biomaterial Wound Dressing Market, By Application

  • 8.1 Introduction
  • 8.2 Acute Wounds
    • 8.2.1 Surgical Wounds
    • 8.2.2 Burns
  • 8.3 Chronic Wounds
    • 8.3.1 Diabetic Foot Ulcers
    • 8.3.2 Venous Leg Ulcers
    • 8.3.1 Pressure Ulcers
  • 8.4 Traumatic Wounds
  • 8.5 Other Applications

9 Global Biomaterial Wound Dressing Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Clinics
  • 9.3 Home Care Settings
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Long-Term Care Facilities
  • 9.6 Other End Users

10 Global Biomaterial Wound Dressing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 3M Health Care
  • 12.2 Johnson & Johnson
  • 12.3 Smith & Nephew
  • 12.4 Medtronic
  • 12.5 Molnlycke Health Care
  • 12.6 ConvaTec Group
  • 12.7 Coloplast
  • 12.8 BSN Medical
  • 12.9 Hollister Incorporated
  • 12.10 Systagenix Wound Management
  • 12.11 Derma Sciences
  • 12.12 KCI
  • 12.13 B. Braun Melsungen AG
  • 12.14 Medi-USA
  • 12.15 Integra LifeSciences Corporation

List of Tables

  • Table 1 Global Biomaterial Wound Dressing Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biomaterial Wound Dressing Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Biomaterial Wound Dressing Market Outlook, By Foam Dressings (2022-2030) ($MN)
  • Table 4 Global Biomaterial Wound Dressing Market Outlook, By Hydrocolloid Dressings (2022-2030) ($MN)
  • Table 5 Global Biomaterial Wound Dressing Market Outlook, By Hydrogels (2022-2030) ($MN)
  • Table 6 Global Biomaterial Wound Dressing Market Outlook, By Film Dressings (2022-2030) ($MN)
  • Table 7 Global Biomaterial Wound Dressing Market Outlook, By Composite Dressings (2022-2030) ($MN)
  • Table 8 Global Biomaterial Wound Dressing Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Biomaterial Wound Dressing Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 10 Global Biomaterial Wound Dressing Market Outlook, By Collagen (2022-2030) ($MN)
  • Table 11 Global Biomaterial Wound Dressing Market Outlook, By Chitosan (2022-2030) ($MN)
  • Table 12 Global Biomaterial Wound Dressing Market Outlook, By Silicone (2022-2030) ($MN)
  • Table 13 Global Biomaterial Wound Dressing Market Outlook, By Hydrocolloid (2022-2030) ($MN)
  • Table 14 Global Biomaterial Wound Dressing Market Outlook, By Foam (2022-2030) ($MN)
  • Table 15 Global Biomaterial Wound Dressing Market Outlook, By Alginate (2022-2030) ($MN)
  • Table 16 Global Biomaterial Wound Dressing Market Outlook, By Other Material Types (2022-2030) ($MN)
  • Table 17 Global Biomaterial Wound Dressing Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 18 Global Biomaterial Wound Dressing Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 19 Global Biomaterial Wound Dressing Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 20 Global Biomaterial Wound Dressing Market Outlook, By Online Sales (2022-2030) ($MN)
  • Table 21 Global Biomaterial Wound Dressing Market Outlook, By Hospitals and Healthcare Providers (2022-2030) ($MN)
  • Table 22 Global Biomaterial Wound Dressing Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Biomaterial Wound Dressing Market Outlook, By Acute Wounds (2022-2030) ($MN)
  • Table 24 Global Biomaterial Wound Dressing Market Outlook, By Surgical Wounds (2022-2030) ($MN)
  • Table 25 Global Biomaterial Wound Dressing Market Outlook, By Burns (2022-2030) ($MN)
  • Table 26 Global Biomaterial Wound Dressing Market Outlook, By Chronic Wounds (2022-2030) ($MN)
  • Table 27 Global Biomaterial Wound Dressing Market Outlook, By Diabetic Foot Ulcers (2022-2030) ($MN)
  • Table 28 Global Biomaterial Wound Dressing Market Outlook, By Venous Leg Ulcers (2022-2030) ($MN)
  • Table 29 Global Biomaterial Wound Dressing Market Outlook, By Pressure Ulcers (2022-2030) ($MN)
  • Table 30 Global Biomaterial Wound Dressing Market Outlook, By Traumatic Wounds (2022-2030) ($MN)
  • Table 31 Global Biomaterial Wound Dressing Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 32 Global Biomaterial Wound Dressing Market Outlook, By End User (2022-2030) ($MN)
  • Table 33 Global Biomaterial Wound Dressing Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 34 Global Biomaterial Wound Dressing Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 35 Global Biomaterial Wound Dressing Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 36 Global Biomaterial Wound Dressing Market Outlook, By Long-Term Care Facilities (2022-2030) ($MN)
  • Table 37 Global Biomaterial Wound Dressing Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.